![lee Giguere](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
lee Giguere
Plus aucun poste en cours
Fortune : - $ au 30/06/2026
Profil
lee G.
Giguere formerly worked at Boston Scientific Corp., as Senior Securities & Governance Counsel from 2013 to 2016, Chiasma, Inc., as Secretary, Vice President & General Counsel from 2019 to 2021, Karyopharm Therapeutics, Inc., as Deputy General Counsel from 2018 to 2019, Obsidian Therapeutics, Inc., as Secretary & Chief Legal Office from 2021 to 2024, Goodwin Procter LLP, as Head-Business Law Department from 2006 to 2013, and enGene Therapeutics, Inc., as Secretary & Chief Legal Officer from 2024 to 2026.
Dr. Giguere received his undergraduate degree from Northeastern University and graduate degree from Northeastern University School of Law.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/01/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
Anciens postes connus de lee Giguere
| Sociétés | Poste | Fin |
|---|---|---|
| ENGENE THERAPEUTICS INC. | Conseiller Juridique Général | 15/07/2026 |
Obsidian Therapeutics, Inc.
 Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops TIL cell therapies for the treatment of patients with solid tumors | Conseiller Juridique Général | 01/01/2024 |
| CHIASMA, INC. | Conseiller Juridique Général | 05/08/2021 |
| KARYOPHARM THERAPEUTICS INC. | Corporate Officer/Principal | 01/09/2019 |
| BOSTON SCIENTIFIC CORPORATION | Corporate Officer/Principal | 01/09/2016 |
Formation de lee Giguere
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
61
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Boston Scientific Corp.
 Boston Scientific Corp. Medical SpecialtiesHealth Technology Develops, manufactures and markets cardiology, endoscopy, peripheral intervention, urology & neuromodulation equipment | Health Technology |
Chiasma, Inc.
 Chiasma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops treatments for rare and serious chronic disease | Health Technology |
Goodwin Procter LLP
 Goodwin Procter LLP Investment ManagersFinance Functions as an alternative investment manager | Finance |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Karyopharm Therapeutics, Inc.
 Karyopharm Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel drugs for the treatment of cancer, inflammation and other diseases related to cell proliferation | Health Technology |
Northeastern University School of Law
 Northeastern University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Obsidian Therapeutics, Inc.
Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops TIL cell therapies for the treatment of patients with solid tumors | Health Technology |
enGene Holdings, Inc.
 enGene Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that develops, manufactures and sells non-viral genetic medicines | Commercial Services |
